These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11494176)

  • 1. Meningococcal serogroup a avidity indices as a surrogate marker of priming for the induction of immunologic memory after vaccination with a meningococcal A/C conjugate vaccine in infants in the United Kingdom.
    Joseph H; Miller E; Dawson M; Andrews N; Feavers I; Borrow R
    J Infect Dis; 2001 Sep; 184(5):661-2. PubMed ID: 11494176
    [No Abstract]   [Full Text] [Related]  

  • 2. Is a single infant priming dose of meningococcal serogroup C conjugate vaccine in the United Kingdom sufficient?
    Findlow H; Borrow R
    Hum Vaccin Immunother; 2015; 11(6):1501-6. PubMed ID: 25912095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom.
    Zhang Q; Lakshman R; Burkinshaw R; Choo S; Everard J; Akhtar S; Finn A
    Infect Immun; 2001 Jul; 69(7):4337-41. PubMed ID: 11401971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers.
    Richmond P; Borrow R; Goldblatt D; Findlow J; Martin S; Morris R; Cartwright K; Miller E
    J Infect Dis; 2001 Jan; 183(1):160-3. PubMed ID: 11078484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults.
    Southern J; Deane S; Ashton L; Borrow R; Goldblatt D; Andrews N; Balmer P; Morris R; Kroll JS; Miller E
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1100-4. PubMed ID: 15539513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
    Perrett KP; Snape MD; Ford KJ; John TM; Yu LM; Langley JM; McNeil S; Dull PM; Ceddia F; Anemona A; Halperin SA; Dobson S; Pollard AJ
    Pediatr Infect Dis J; 2009 Mar; 28(3):186-93. PubMed ID: 19209097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of immunological memory in UK infants by a meningococcal A/C conjugate vaccine.
    Borrow R; Fox AJ; Richmond PC; Clark S; Sadler F; Findlow J; Morris R; Begg NT; Cartwright KA
    Epidemiol Infect; 2000 Jun; 124(3):427-32. PubMed ID: 10982066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.
    Borrow R; Andrews N; Goldblatt D; Miller E
    Infect Immun; 2001 Mar; 69(3):1568-73. PubMed ID: 11179328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune memory in children previously vaccinated with an experimental quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine.
    Pichichero M; Papa T; Blatter M; Mitchell D; Kratz R; Sneed J; Bassily E; Casey J; Gilmet G
    Pediatr Infect Dis J; 2006 Nov; 25(11):995-1000. PubMed ID: 17072120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy.
    MacLennan J; Obaro S; Deeks J; Lake D; Elie C; Carlone G; Moxon ER; Greenwood B
    J Infect Dis; 2001 Jan; 183(1):97-104. PubMed ID: 11087205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal serogroup C polysaccharide specific memory B cells, directly enumerated by labeled polysaccharide, are not affected by age at vaccination.
    Henneken M; Burdin N; Thoroddsen E; Sigurdardottir ST; Trannoy E; Jonsdottir I
    Vaccine; 2010 Feb; 28(9):2097-103. PubMed ID: 20056181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens.
    Kelly DF; Pollard AJ; Moxon ER
    JAMA; 2005 Dec; 294(23):3019-23. PubMed ID: 16414950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom.
    Auckland C; Gray S; Borrow R; Andrews N; Goldblatt D; Ramsay M; Miller E
    J Infect Dis; 2006 Dec; 194(12):1745-52. PubMed ID: 17109348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and immunological priming of the serogroup a portion of a bivalent meningococcal A/C conjugate vaccine in 2-year-old children.
    Joseph H; Ryall R; Bybel M; Papa T; MacLennan J; Buttery J; Borrow R
    J Infect Dis; 2003 Apr; 187(7):1142-6. PubMed ID: 12660929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serologic correlates of protection for evaluating the response to meningococcal vaccines.
    Balmer P; Borrow R
    Expert Rev Vaccines; 2004 Feb; 3(1):77-87. PubMed ID: 14761245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody persistence 12 months after a booster dose of meningococcal-C conjugated vaccine in the second year of life.
    Diez-Domingo J; Planelles-Cantarino MV; Baldo-Torrenti JM; Ubeda-Sansano I; Jubert-Rosich A; Puig-Barbera J; Gutierrez-Gimeno MV
    Pediatr Infect Dis J; 2010 Aug; 29(8):768-70. PubMed ID: 20375851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
    McVernon J; Nolan T; Richmond P; Reynolds G; Nissen M; Lambert SB; Marshall H; Papa T; Rehm C
    Pediatr Infect Dis J; 2012 Jan; 31(1):e15-23. PubMed ID: 22094636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming for immunologic memory in adults by meningococcal group C conjugate vaccination.
    Vu DM; de Boer AW; Danzig L; Santos G; Canty B; Flores BM; Granoff DM
    Clin Vaccine Immunol; 2006 Jun; 13(6):605-10. PubMed ID: 16760316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant can improve protection induced by OMV vaccine against Neisseria meningitidis serogroups B/C in neonatal mice.
    Fukasawa LO; Dias WO; Schenkman RP; Raw I; Tanizaki MM
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):205-10. PubMed ID: 15196569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines.
    Slack MH; Schapira D; Thwaites RJ; Burrage M; Southern J; Andrews N; Borrow R; Goldblatt D; Miller E
    J Infect Dis; 2001 Dec; 184(12):1617-20. PubMed ID: 11740740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.